The U.S. Food and Drug Administration approved Arrowhead Pharmaceuticals' drug for a type of genetic disorder that causes ...

Plozasiran is an apoC-III-directed small interfering ribonucleic acid designed to reduce levels of hepatic and serum apoC-III ...

A menopause researcher breaks down the biggest myths women get wrong about hot flashes, plus the hormonal and non-hormonal ...

The next generation of weight loss drugs will hit the market in 2026. Eli Lilly and Novo Nordisk are racing to the finish line.

President Donald Trump has repeatedly claimed that strikes on suspected drug boats his administration began carrying out in ...

Two "priority targets" of the U.S. DEA as well as suspected members of the Italian mafia were among 20 people detained, ...

(WJW) – The recall of a baby formula believed to be linked to multiple botulism cases is now being expanded to include all ...

The Food and Drug Administration shouldn’t be in the news if it’s doing its job right. By that measure the FDA is failing in spectacular fashion. The agency this week is making news for all of the ...

Risk of “acute, serious, and life-threatening” heart inflammation is now on the label of Sarepta's gene therapy for Duchenne ...

A GOP congresswoman is circulating a bill that would stop the implementation of a federal hemp THC product ban that’s part of ...